Importantly, such cancer therapeutic efficacy was also observed in A549 xenografts with in situ transfection of TRPV2 (Supplementary Fig. 14), indicating this technique is able to work across multiple tumour types without the limitation of endogenous TRPV2 expression. This evidence concerns the gene TRPV2 and cancer.